<p>Arbetsbelastningen för föraren i en engreppsskördare är stor. Vid aptering måste föraren fokusera om blicken för att läsa av information från en Head-Down Display (HDD) samtidigt som föraren måste ha kontroll på kranspetsen vilket bidrar till arbetsbelastningen.</p><p>Syftet med projektet var att undersöka om arbetsbelastningen i engreppsskördare reducerades med Head-Up Display (HUD) under aptering. Först testades fyra HUD-gränssnitt i en simulator, därefter omarbetades gränssnitten innan de slutligen testades i en engreppsskördare i fält. En HUD-demonstrator utvecklades för detta ändamål.</p><p>Resultatet visade att arbetsbelastningen samt apteringstiderna minskade i simulatortestet med HUD jämfört med HDD. I fältstudien förblev arbetsbelastningen oförändrad men apteringstiderna minskade.</p><p>Att arbetsbelastningen minskade med HUD jämfört med HDD kan bero på att HUD är bättre än HDD och/eller att konceptens gränssnitt är effektivare att arbeta med än Valmet Maxi gränssnittet.</p><p>En HUD-demonstrator som fungerar under ljusstarka förhållanden och som tål påfrestningarna i en skördare borde utvecklas för vidare tester.</p>

Arbetsbelastningen för föraren i en engreppsskördare är stor. Vid aptering måste föraren fokusera om blicken för att läsa av information från en Head-Down Display (HDD) samtidigt som föraren måste ha kontroll på kranspetsen vilket bidrar till arbetsbelastningen. Syftet med projektet var att undersöka om arbetsbelastningen i engreppsskördare reducerades med Head-Up Display (HUD) under aptering. Först testades fyra HUD-gränssnitt i en simulator, därefter omarbetades gränssnitten innan de slutligen testades i en engreppsskördare i fält. En HUD-demonstrator utvecklades för detta ändamål. Resultatet visade att arbetsbelastningen samt apteringstiderna minskade i simulatortestet med HUD jämfört med HDD. I fältstudien förblev arbetsbelastningen oförändrad men apteringstiderna minskade. Att arbetsbelastningen minskade med HUD jämfört med HDD kan bero på att HUD är bättre än HDD och/eller att konceptens gränssnitt är effektivare att arbeta med än Valmet Maxi gränssnittet. En HUD-demonstrator som fungerar under ljusstarka förhållanden och som tål påfrestningarna i en skördare borde utvecklas för vidare tester.

Various models of simulated weightlessness and resulting cardiovascular effects have been researched in the last 50 years of space exploration. Examples of such models are the Alter-G (Alt-G) treadmill used for body unweighting and head-up-tilt (HUT) model each providing similar cardiovascular effects, but differing in their stimulation of vestibular centers . Advantages of using the Alt-G include: use of lower body positive pressure (LBPP) to simulate hypogravity, it acts as a countermeasure to alleviate negative cardiovascular effects of standing and provides a constant vestibular stimulus. In addition, the Alt-G shorts themselves may be providing a certain degree of LBPP, acting as a compression garment. Therefore the purpose of this study was to determine the cardiovascular effects of Alt-G shorts and how effective they are as countermeasure to deconditioning effects of space flight. This study tested cardiovascular changes in 12 men and women at 0 and 80 degrees head-up-tilt (HUT0 / HUT80) with and without Alt-G shorts using 5-lead ECG, 10-lead impedance, heart rate, systolic and diastolic blood pressure measurements at finger and arm. The tilt-induced increase in mean heart rate (HR) was significantly smaller when subjects wore the Alt-G shorts. Shorts ended up reducing HR by 2.3 bpm in supine control and by 6.7 bpm at HUT80 (p0.05. Other cardiovascular variables did not show any significant effect from shorts. In conclusion, this study was in line with results from other studies that used compression garments to determine cardiovascular effects of LBPP.

INTRODUÇÃO: Síncope inexplicada é considerada um fator de risco de morte súbita na cardiomiopatia hipertrófica (CMH). Em sua patogênese estão envolvidos meca-nismos diversos, incluindo a dificuldade de adaptação da resistência vascular sistêmica ao exercício e ao estresse ortostático, que pode ser influenciada por uma disfunção do sistema nervoso autônomo. Os objetivos deste estudo foram comparar a função nervosa autonômica em portadores de CMH com e sem síncope, bem como avaliar o valor diagnóstico do teste de inclinação (TI) na investigação de síncope nessa população. MÉTODOS: Foram incluídos 37 pacientes, 16 com síncope inexplicada à avaliação rotineira e 21 sem síncope. A função nervosa autonômica foi medida pela sensibilidade do barorreflexo (BR) espontâneo e do induzido por fenilefrina e pela variabilidade da freqüência cardíaca (VFC). As variáveis da VFC consideradas no domínio do tempo foram: desvio-padrão de todos os intervalos RR normais (SDNN); raiz quadrada da média do quadrado das diferenças entre intervalos RR normais adjacentes (RMSSD); e percentagem de intervalos RR adjacentes com diferença superior a 50 ms (pNN50), durante o eletrocardiograma de 24 horas. No domínio da freqüência, foram considerados os componentes de alta, baixa e muito baixa freqüência e a densidade total do espectro, tanto em valores absolutos como em unidades normalizadas, em repouso e aos 60 graus de inclinação. As medidas da pressão arterial sistólica e diastólica, batimento a batimento, e as medidas do índice sistólico, do índice cardíaco e da resistência vascular sistêmica, obtidas pela cardiografia por impedância, foram comparadas, entre os grupos, a 0, 30 e 60 graus de inclinação. O TI consistiu na exposição dos pacientes a 60º de inclinação por 40 minutos, ou até uma resposta positiva. RESULTADOS: A sensibilidade do BR, tanto espontâneo (16,46±12,99 vs 18,31±9,88 ms/mmHg, p=0,464) como induzido por fenilefrina (18,33±9,31 vs 15,83±15,48 ms/mmHg, p=0,521) foi semelhante nos grupos síncope e sem síncope. Não foram observadas diferenças nos valores de SDNN (137,69±36,62 vs 145,95±38,07 ms, p=0,389). O grupo síncope apresentou menores valores de RMSSD (24,88±10,03 vs 35,58±16,43 ms, p=0,042) e tendência a menor pNN50 (4,51±3,78 vs 8,83±7,98 %, p=0,085) e a menores valores do componente de alta freqüência da análise espectral, em repouso (637,59±1295,53 vs 782,65±1264,14 ms2, p=0,075). Não foram observadas diferenças significativas entre os grupos nos demais parâmetros analisados no domínio da freqüência. A adaptação das variáveis hemodinâmicas aos diferentes graus de inclinação foi semelhante entre os grupos nas várias posições estudadas. A positividade ao TI foi semelhante nos dois grupos (6% no grupo síncope e 33% no sem síncope, p=0,053). A sensibilidade, a especificidade e a acurácia do TI em identificar a causa da síncope na amostra foram, respectivamente, 6%, 66% e 40%. CONCLUSÃO: Uma menor atividade parassimpática, medida pela VFC, foi observada nos portadores de CMH com síncope. Não foram encontradas diferenças na reserva vagal e na adaptação hemodinâmica ao estresse ortostático entre os grupos. O TI revelou-se com baixa sensibilidade, especificidade e acurácia para o diagnóstico de síncope inexplicada nessa população. / BACKGROUND: Unexplained syncope is considered a risk factor for sudden death in hypertrophic cardiomyopathy (HCM). Several mechanisms are involved in its pathogenesis, including the difficulty in adaptation of the systemic vascular resistance to exertion and to orthostatic stress, which may be influenced by a dysfunction of the autonomic nervous system. The purposes of this study were to compare the autonomic nervous function in patients with HCM with and without syncope and to assess diagnostic value of the head-up tilting test (HUT) in this population. METHODS: Thirty seven patients were included: 16 with unexplained syncope at routine evaluation and 21 without syncope. The autonomic nervous function was assessed by spontaneous and phenylephrine-induced baroreflex sensitivity (BRS) and by heart rate variability (HRV). Considered HRV variables in time domain were: standard deviation of normal RR intervals (SDNN), root mean square of successive differences (RMSSD), and percentage of adjacent normal RR intervals which differ by at least 50 ms (pNN50), during 24 hours electrocardiogram recording. In frequency domain, high, low and very low frequency bands and the spectrum total power density were considered, both in absolute values and in normalized units, at rest and at 60-degree tilting. Measures of systolic and diastolic blood pressure, beat to beat, and measures of stroke index, cardiac index, and systemic vascular resistance, obtained by impedance cardiography, were compared between the groups, at 0-, 30- and 60-degree tilting. The HUT consisted in exposure to 60º for 40 minutes, or until a positive response. RESULTS: Spontaneous BRS measures were similar between the syncope and non-syncope groups (16.46±12.99 vs 18.31±9.88 ms/mmHg, p=0.464), as well as phenylephrine induced BRS (18.33±9.31 vs 15.83±15.48 ms/mmHg, p=0.521). No differences were found between SDNN values (137.69±36.62 vs 145.95±38.07 ms, p=0.389). The syncope group presented lower values of RMSSD (24.88±10.03 vs 35.58±16.43 ms, p=0.042) and a trend to lower pNN50 (4.51±3.78 vs 8.83±7.98 %, p=0.085) and to lower high frequency component of spectral analyses at rest (637.59±1295.53 vs 782.65±1264.14 ms2, p= 0.075). No differences were observed between the groups in the others parameters analyzed in the frequency domain. Adaptation of hemodynamic variables at different tilting degrees was similar between the groups at the various positions studied. Positive responses to HUT were similar in the two groups (6% in syncope group and 33% in no-syncope group; p=0.053). HUT sensitivity, specificity and accuracy in identifying the cause of syncope in this population were, respectively, 6%, 66% and 40%. CONCLUSION: A lower parasympathetic activity, measured by HRV, was observed in HCM patients with syncope. No differences were found in vagal reserve and in adaptation to orthostatic stress between the groups. HUT showed poor sensitivity, specificity and accuracy in diagnosing unexplained syncope in this population.

Orthostatic hypotension is a common problem for individuals with spinal cord lesions, especially in the acute period after spinal cord injury. The first part of this study deals with the theoretical analysis of the pathophysiology of cardiovascular control after spinal cord injury, the definition of orthostatic hypotension and its inclusion within the classification of the syncopal conditions. An important part of the theoretical part is the management of orthostatic hypotension, which brings non-pharmacological therapeutic approaches, and marginally pharmacology, to decrease the severity of this condition. The experimental part focuses on testing of a group of probands with spinal cord injury (11 quadriplegics) on two different types of tilt tables according to the same protocol. The first tilt table is a standard; the second one is Erigo, tilt table with integrated robotic mechanism, which moves the legs to simulate walking. The parameters, such as blood pressure, heart rate, oxygen saturation, and the occurrence and severity of pre-synkopal symptoms, were compared. The study is based on the assumption that passive leg movement, which is mediated by the Erigo, will maintain venous return, cardiac output, and a significant drop in blood pressure and development of orthostatic hypotension,...

Pilot spatial disorientation (SD) is a significant cause of incidents and fatal accidents in aviation. The pilot is susceptible to SD especially in low visibility when the visual system is deprived of information from outside the cockpit. This thesis presents the notion of visual flow displays as enhancement of symbology on flight displays primarily in low visibility for improved support of the pilot’s spatial orientation (SO) and control actions. In Studies I and II, synthetic visual flow of forward ego-motion was presented on displays and postural responses were used as measures of display effectiveness in determining SO. The visual flow significantly affected SO, and although the increased stimulation of the visual periphery from a width of 45° to about 105° increased the effects there was no further effect at a width of about 150° (Studies I and II). Studies I and II also showed that omitting 20°- or 30°-wide central fields of view from the visual flow either reduced or not reduced the effects. Further, although inconclusive, Study II may indicate that horizon symbology in central visual field may enhance the effects of peripheral visual flow. The appropriate integration of peripheral visual flow with the head-up display symbology of the Gripen aircraft was presented. Acceleration in a human centrifuge was used in Study III to investigate the effects of synthetic visual flow on the primarily vestibular-dependent somatogravic illusion of pitch-up. Two experiments revealed a reduced illusion with the visual flow. The results of Experiment 2 showed the visual flow scene not only reduced the illusion compared with a darkness condition but also compared with the visual scene without visual flow. Thus, similar to the main findings of Studies I and II, synthetic visual flow can significantly affect SO and supports the visually dependent SO system in an essential manner.

Introdução: Síncope e sintomas ortostáticos são comuns em pessoas saudáveis. A suplementação de sal é utilizada em pacientes com melhora na resposta pressora e aumento da tolerância ortostática. Nós testamos à hipótese de que uma suplementação de sal aumentaria a tolerância ortostática em voluntários saudáveis. Métodos e Resultados: Vinte voluntários saudáveis (13 do sexo feminino, idade 29 ± 5,6 anos), sem história de síncope, foram submetidos ao teste inclinação ortostática, em um ângulo de 70 graus, por 35 minutos ou até que sintomas de pré-síncope ou síncope fossem observados. Foram randomizados e cruzados para receber 6g de sal em um dos exames e placebo no outro, 3 horas antes, em um protocolo duplo-cego. Para avaliar para-efeitos, foram avaliados índices clínicos e laboratoriais. A ingestão de sal melhorou a tolerância ortostática em 11 de 12 voluntários (55%) que apresentaram présincope ou síncope (variação de 1 a 6 minutos). O tempo com a suplementação de sal foi de 33,35 ± 4,1 minutos e com placebo 31,95 ± 4,4 minutos (média ± DP; p = 0,009), a tolerância ortostática diferiu em 1,4 ± 2,09 minutos (IC 95%, 0,42 - 2,37 minutos). A pressão arterial sistólica, a diastólica e a freqüência cardíaca na posição supina não alteraram de forma significativa. No entanto, a pressão arterial sistólica e a diastólica (120,85 ± 30,9 e 78,75 ± 20,6 mmHg) mantiveram-se mais elevadas ao término do exame com a suplementação de sal quando comparadas com o placebo (99,2 ± 29,8 e 64 ± 21 mmHg; p = 0,006 e p = 0,007, respectivamente). Conclusão: A suplementação de sal parece melhorar a tolerância ortostática em voluntários saudáveis, sem alterar as variáveis clínicas em repouso. / Background: Orthostatic symptoms and syncope are common in healthy subjects. Salt supplementation can be used in patients showing improvement in the pressor response and increase in the orthostatic tolerance. We tested the hypothesis that single salt supplementation increases the orthostatic tolerance in healthy subjects. Methods e Results: Twenty healthy volunteers (13 females, 29.05 ± 5.57 years old), without syncope history, were submitted to head-up tilt test, at an angle of 70 degrees, for 35 minutes or until presyncope or syncope were observed. They were randomized and crossover to receive 6g of salt in one of the exams and placebo in the other, 3 hours before, in a double-blind protocol. To evaluate for side effects, there were evaluate clinical and laboratorial indexes. Ingestion of salt improved orthostatic tolerance in 11 out of 12 volunteers who presented presyncope or syncope (variation from 1 to 6 minutes). The time with salt supplementation was of 33.35 ± 4.1 minutes and with placebo it was of 31.95 ± 4.4 minutes (mean ± SD; p = 0.009), orthostatic tolerance differed in 1.4 ± 2.09 minutes (95% CI, 0.42 - 2.37 minutes). Systolic and diastolic blood pressure and heart rate in the supine position did not change significantly with salt or with the placebo. However, Systolic and diastolic blood pressure with salt supplementation (120.85 ± 30.9 mmHg and 78.75 ± 20.6 mmHg) were higher at the end of the exam when compared to placebo (99.2 ± 29.8 and 64 ± 21 mmHg; p = 0.006 and p = 0.007, respectively). Conclusion: Salt supplementation seems to improve orthostatic tolerance in healthy volunteers without changing clinical variables at rest.

Introdução: Síncope e sintomas ortostáticos são comuns em pessoas saudáveis. A suplementação de sal é utilizada em pacientes com melhora na resposta pressora e aumento da tolerância ortostática. Nós testamos à hipótese de que uma suplementação de sal aumentaria a tolerância ortostática em voluntários saudáveis. Métodos e Resultados: Vinte voluntários saudáveis (13 do sexo feminino, idade 29 ± 5,6 anos), sem história de síncope, foram submetidos ao teste inclinação ortostática, em um ângulo de 70 graus, por 35 minutos ou até que sintomas de pré-síncope ou síncope fossem observados. Foram randomizados e cruzados para receber 6g de sal em um dos exames e placebo no outro, 3 horas antes, em um protocolo duplo-cego. Para avaliar para-efeitos, foram avaliados índices clínicos e laboratoriais. A ingestão de sal melhorou a tolerância ortostática em 11 de 12 voluntários (55%) que apresentaram présincope ou síncope (variação de 1 a 6 minutos). O tempo com a suplementação de sal foi de 33,35 ± 4,1 minutos e com placebo 31,95 ± 4,4 minutos (média ± DP; p = 0,009), a tolerância ortostática diferiu em 1,4 ± 2,09 minutos (IC 95%, 0,42 - 2,37 minutos). A pressão arterial sistólica, a diastólica e a freqüência cardíaca na posição supina não alteraram de forma significativa. No entanto, a pressão arterial sistólica e a diastólica (120,85 ± 30,9 e 78,75 ± 20,6 mmHg) mantiveram-se mais elevadas ao término do exame com a suplementação de sal quando comparadas com o placebo (99,2 ± 29,8 e 64 ± 21 mmHg; p = 0,006 e p = 0,007, respectivamente). Conclusão: A suplementação de sal parece melhorar a tolerância ortostática em voluntários saudáveis, sem alterar as variáveis clínicas em repouso. / Background: Orthostatic symptoms and syncope are common in healthy subjects. Salt supplementation can be used in patients showing improvement in the pressor response and increase in the orthostatic tolerance. We tested the hypothesis that single salt supplementation increases the orthostatic tolerance in healthy subjects. Methods e Results: Twenty healthy volunteers (13 females, 29.05 ± 5.57 years old), without syncope history, were submitted to head-up tilt test, at an angle of 70 degrees, for 35 minutes or until presyncope or syncope were observed. They were randomized and crossover to receive 6g of salt in one of the exams and placebo in the other, 3 hours before, in a double-blind protocol. To evaluate for side effects, there were evaluate clinical and laboratorial indexes. Ingestion of salt improved orthostatic tolerance in 11 out of 12 volunteers who presented presyncope or syncope (variation from 1 to 6 minutes). The time with salt supplementation was of 33.35 ± 4.1 minutes and with placebo it was of 31.95 ± 4.4 minutes (mean ± SD; p = 0.009), orthostatic tolerance differed in 1.4 ± 2.09 minutes (95% CI, 0.42 - 2.37 minutes). Systolic and diastolic blood pressure and heart rate in the supine position did not change significantly with salt or with the placebo. However, Systolic and diastolic blood pressure with salt supplementation (120.85 ± 30.9 mmHg and 78.75 ± 20.6 mmHg) were higher at the end of the exam when compared to placebo (99.2 ± 29.8 and 64 ± 21 mmHg; p = 0.006 and p = 0.007, respectively). Conclusion: Salt supplementation seems to improve orthostatic tolerance in healthy volunteers without changing clinical variables at rest.

At night or in bad weather, the task of driving is very complex since the amount of visual information available is severely reduced. Vision Enhancement Systems may compensate for parts of the missing information by supplying the driver with a picture of the world where warm objects are made visible. This thesis investigates the impact of Vision Enhancement System display types on cognitive capture and driving performance. 16 subjects were recruited for a simulator study. It was hypothesised that when the contrast of a transparent display is high enough for the driver to separate the picture from the background and make out enough details to interpret it, the risk of cognitive capture is higher than when using an opaque display with the same objects visible. The subjects’ driving performance and opinions about the driving experience were also investigated. No significant differences in driving performance or level of cognitive capture was found. However, questionnaire answers indicate that this question needs to be investigated further to find out whether one display type is preferable because of better and safer driving performance or if individual differences between drivers require the possibility to choose the display type of their personal preference.

Introdução: Síncope e sintomas ortostáticos são comuns em pessoas saudáveis. A suplementação de sal é utilizada em pacientes com melhora na resposta pressora e aumento da tolerância ortostática. Nós testamos à hipótese de que uma suplementação de sal aumentaria a tolerância ortostática em voluntários saudáveis. Métodos e Resultados: Vinte voluntários saudáveis (13 do sexo feminino, idade 29 ± 5,6 anos), sem história de síncope, foram submetidos ao teste inclinação ortostática, em um ângulo de 70 graus, por 35 minutos ou até que sintomas de pré-síncope ou síncope fossem observados. Foram randomizados e cruzados para receber 6g de sal em um dos exames e placebo no outro, 3 horas antes, em um protocolo duplo-cego. Para avaliar para-efeitos, foram avaliados índices clínicos e laboratoriais. A ingestão de sal melhorou a tolerância ortostática em 11 de 12 voluntários (55%) que apresentaram présincope ou síncope (variação de 1 a 6 minutos). O tempo com a suplementação de sal foi de 33,35 ± 4,1 minutos e com placebo 31,95 ± 4,4 minutos (média ± DP; p = 0,009), a tolerância ortostática diferiu em 1,4 ± 2,09 minutos (IC 95%, 0,42 - 2,37 minutos). A pressão arterial sistólica, a diastólica e a freqüência cardíaca na posição supina não alteraram de forma significativa. No entanto, a pressão arterial sistólica e a diastólica (120,85 ± 30,9 e 78,75 ± 20,6 mmHg) mantiveram-se mais elevadas ao término do exame com a suplementação de sal quando comparadas com o placebo (99,2 ± 29,8 e 64 ± 21 mmHg; p = 0,006 e p = 0,007, respectivamente). Conclusão: A suplementação de sal parece melhorar a tolerância ortostática em voluntários saudáveis, sem alterar as variáveis clínicas em repouso. / Background: Orthostatic symptoms and syncope are common in healthy subjects. Salt supplementation can be used in patients showing improvement in the pressor response and increase in the orthostatic tolerance. We tested the hypothesis that single salt supplementation increases the orthostatic tolerance in healthy subjects. Methods e Results: Twenty healthy volunteers (13 females, 29.05 ± 5.57 years old), without syncope history, were submitted to head-up tilt test, at an angle of 70 degrees, for 35 minutes or until presyncope or syncope were observed. They were randomized and crossover to receive 6g of salt in one of the exams and placebo in the other, 3 hours before, in a double-blind protocol. To evaluate for side effects, there were evaluate clinical and laboratorial indexes. Ingestion of salt improved orthostatic tolerance in 11 out of 12 volunteers who presented presyncope or syncope (variation from 1 to 6 minutes). The time with salt supplementation was of 33.35 ± 4.1 minutes and with placebo it was of 31.95 ± 4.4 minutes (mean ± SD; p = 0.009), orthostatic tolerance differed in 1.4 ± 2.09 minutes (95% CI, 0.42 - 2.37 minutes). Systolic and diastolic blood pressure and heart rate in the supine position did not change significantly with salt or with the placebo. However, Systolic and diastolic blood pressure with salt supplementation (120.85 ± 30.9 mmHg and 78.75 ± 20.6 mmHg) were higher at the end of the exam when compared to placebo (99.2 ± 29.8 and 64 ± 21 mmHg; p = 0.006 and p = 0.007, respectively). Conclusion: Salt supplementation seems to improve orthostatic tolerance in healthy volunteers without changing clinical variables at rest.